Baltimore City has secured an $80 million settlement with Walgreens, adding to its total opioid-related recoveries of $402.5 million. This follows previous settlements with CVS, Allergan, Cardinal Health, and Teva Pharmaceuticals. The city will use the funds for various outreach and treatment programs, including the 988 Help Line and local recovery centers. A lawsuit against Johnson & Johnson, McKesson, and AmerisourceBergen is set for trial next week. Mayor Brandon Scott emphasized the importance of these settlements in providing resources to combat the opioid crisis. Baltimore opted out of global settlements to pursue larger individual payouts.